Surgery increases risk of conjunctival scars

Article

A greater number of mast cells are present in the conjunctiva of glaucoma patients who have undergone ocular surgery, possibly leading to increased scarring, according to study results published online ahead of print by Eye.

A greater number of mast cells are present in the conjunctiva of glaucoma patients who have undergone ocular surgery, possibly leading to increased scarring, according to study results published online ahead of print by Eye.

Lydia Chang of the Paediatric Glaucoma Service at Moorfields Eye Hospital, London, UK and colleagues identified the presence of tryptase, the intracellular mast cell enzyme, in the conjunctiva of glaucoma patients treated medically (n=6), with repeated surgery (n=8) and for uveitic glaucoma (n=7). They compared the tryptase levels with those found in the conjunctival biopsies of the control group (retinal detachment patients, n=8).

The median tryptase level of the control group was 0.064 cells/mm2; among the glaucoma groups, the median level ranged from 0.102 cells/mm2 to 0.113 cells/mm2. There was a statistically significant difference between the tryptase level of the surgery glaucoma group when compared with control, although this statistically significant difference did not exist between the control group and either of the other glaucoma groups.

Because the tryptase levels were higher in glaucoma patients who had previously undergone surgery, the researchers concluded that the activity of mast cells may contribute to post-trabeculectomy conjunctival scarring.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.